
March 24, 2026 8:10 PM


Sanofi to Buy Dynavax for $2.2 Billion to Strengthen Adult Vaccine Portfolio

FDA Initiates New Safety Review of Infant RSV Preventive Therapies Amid Controversy

Genmab Halts Cancer Drug Development, Refocusing on Higher-Priority Therapies

US to Allow Asylum Denials on Public Health Grounds Under New Trump-Era Rule

Ultragenyx Stock Crashes After Experimental Bone Disease Drug Misses Key Trial Goal

Novo Nordisk Slashes Wegovy Prices in China Ahead of Rising Competition

Trump Administration Agrees to Reconsider Frozen NIH Research Grants After Legal Challenge

US Launches $50 Billion Rural Health Program, Guaranteeing At Least $147 Million Per State in 2026

One Simple Habit That Helps You Eat Better and Stay Active While Traveling for the Holidays
More From Next Click News
Explore Next Click News Categories